Fifth Third Bancorp Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Fifth Third Bancorp Common Stock trades at $50.41 (market cap $45.98B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.92 (market cap $25.27B). The key difference: Fifth Third Bancorp Common Stock is the larger of the two by market cap, and Fifth Third Bancorp Common Stock pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Fifth Third Bancorp Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| FITB | RPRX | |
|---|---|---|
Market Cap | $45.98B | $25.27B |
Volume | 10,522,320 | 3,671,183 |
Sector | Financials | Health |
52-Week High | $59.37 | $63.96 |
52-Week Low | $40.36 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $63.85B | $32.50B |
Dividend Yield | 3.31% | 1.66% |
Trailing returns across standard periods
Latest headlines on both assets
Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →